Filter Results:
(219)
Show Results For
- All HBS Web (287)
- Faculty Publications (47)
Show Results For
- All HBS Web (287)
- Faculty Publications (47)
Sort by
- 02 May 2017
- First Look
First Look at New Research: May 2, 2017
patent boosts a start-up’s subsequent growth and innovation by facilitating access to funding from VCs, banks, and public investors. Download working paper:... View Details
Keywords: Carmen Nobel
- February 2016
- Article
Bridging Science and Technology Through Academic-Industry Partnerships
By: Sen Chai and Willy C. Shih
Partnerships that foster the translation of scientific advances emerging from academic research organizations into commercialized products at private firms are a policy tool that has attracted increased interest. This paper examines empirical data from the Danish... View Details
Keywords: Economic Development; Technological Change; Government Policy; Technological Innovation; Research and Development; Information Technology; Policy; Technology Industry; Denmark
Chai, Sen, and Willy C. Shih. "Bridging Science and Technology Through Academic-Industry Partnerships." Research Policy 45, no. 1 (February 2016): 148–158.
- 12 Nov 2019
- Research & Ideas
Corporate Innovation Increasingly Benefits from Government Research
Innovation has always relied, to some degree, on government support. But a recent study suggests that public funding might be even more influential than it seems. “Nearly a third of US patents rely directly... View Details
Keywords: by Michael Blanding
- 06 Jun 2017
- First Look
First Look at New Research and Ideas: June 6, 2017
results reveal the critical importance of software portfolio design decisions in developing a portfolio of applications that can evolve and adapt over time. Download working paper: https://www.hbs.edu/faculty/Pages/item.aspx?num=52707 Harvard Business School Case... View Details
Keywords: Sean Silverthorne
- 25 Aug 2015
- First Look
First Look Tuesday
Working Papers Patent Publication and the Market for Ideas By: Hegde, Deepak, and Hong Luo Abstract—In this paper, we study the effect of invention disclosure-through patent... View Details
- 09 Jun 2008
- Lessons from the Classroom
Monetizing IP: The Executive’s Challenge
According to the U.S. Patent and Trademark Office, intellectual property in this country is worth more than $5 trillion—about twice the amount of the current federal budget. The question: Are companies taking advantage of this value? Not... View Details
- 2000
- Other Article
Understanding the Drivers of National Innovative Capacity
By: Jeffrey L. Furman, Michael E. Porter and Scott Stern
Motivated by R&D productivity differences across countries, we evaluate the determinants of country-level international patenting. Our framework is built on the concept of national innovative capacity. Our results suggest that (a) patenting is well-characterized... View Details
Furman, Jeffrey L., Michael E. Porter, and Scott Stern. "Understanding the Drivers of National Innovative Capacity." Academy of Management Best Paper Proceedings (2000).
- 10 May 2016
- First Look
May 10, 2016
build a literature more effectively than they could with less diverse approaches to gathering data. Publisher's link: https://www.hbs.edu/faculty/Pages/item.aspx?num=51015 April 29, 2016 Science The Growing Problem of Patent Trolling By:... View Details
Keywords: Carmen Nobel
- November 2006 (Revised November 2007)
- Case
Strategy in the Twenty First Century Pharmaceutical Industry: Merck & Co. and Pfizer Inc.
By: David J. Collis and Troy Smith
The global pharmaceutical industry has gone through substantial changes in the last few decades and pharmaceutical firms face major challenges including headline-grabbing litigation, imminent patent expirations, new technologies, rising drug development costs, generic... View Details
Keywords: Mergers and Acquisitions; Growth and Development Strategy; Product Development; Research and Development; Corporate Strategy; Pharmaceutical Industry; United States
Collis, David J., and Troy Smith. "Strategy in the Twenty First Century Pharmaceutical Industry: Merck & Co. and Pfizer Inc." Harvard Business School Case 707-509, November 2006. (Revised November 2007.)
- 10 Dec 2009
- Working Paper Summaries
State Owned Entity Reform in Absence of Privatization: Reforming Indian National Laboratories and Role of Leadership
Keywords: by Prithwiraj Choudhury & Tarun Khanna
- 21 Apr 2014
- Research & Ideas
Bio-Piracy: When Western Firms Usurp Eastern Medicine
inspire new research." Choudhury and Khanna also noticed an increase in herbal patent filing in the mid-1990s, despite the publicity of patent-related lawsuits happening at the time: the turmeric case,... View Details
- 26 Nov 2013
- First Look
First Look: November 26
Publications August 2013 Journal of Corporate Finance Golden Parachutes and the Wealth of Shareholders By: Bebchuk, Lucian A., Alma Cohen, and Charles C.Y. Wang Abstract—Golden parachutes (GPs) have attracted substantial attention from... View Details
Keywords: Sean Silverthorne
- Article
Big Names or Big Ideas: Do Peer-Review Panels Select the Best Science Proposals?
By: Danielle Li and Leila Agha
This paper examines the success of peer-review panels in predicting the future quality of proposed research. We construct new data to track publication, citation, and patenting outcomes associated with more than 130,000 research project (R01) grants funded by the U.S.... View Details
Keywords: Patents; Research; Entrepreneurship; Forecasting and Prediction; Innovation and Invention; Business and Government Relations; United States
Li, Danielle, and Leila Agha. "Big Names or Big Ideas: Do Peer-Review Panels Select the Best Science Proposals?" Science 348, no. 6233 (April 24, 2015): 434–438.
- August 2001
- Case
Pharmaceutical Industry and the AIDS Crisis in Developing Countries, The
Explores the controversy over the pricing of AIDS drugs in poor countries. This issue has received wide publicity due to two events: 1) a court case in South Africa that seeks to force drug companies to license their patents and 2) the announcement by the Indian... View Details
Keywords: Competition; Developing Countries and Economies; Business and Government Relations; Pharmaceutical Industry; South Africa; India
Kennedy, Robert E. "Pharmaceutical Industry and the AIDS Crisis in Developing Countries, The." Harvard Business School Case 702-010, August 2001.
- 26 Feb 2007
- Research & Ideas
The Power of the Noncompete Clause
passed, often twelve to twenty-four months. Such a clause, for instance, sparked a public legal battle two years ago when Google hired away a top Microsoft executive, Kai-Fu Lee. But disputes and tensions over noncompetes are not isolated... View Details
Keywords: by Martha Lagace
- 2021
- Working Paper
Technology Differentiation and Firm Performance
By: Sam Arts, Bruno Cassiman and Jianan Hou
Prior work has extensively studied how investing in R&D and building a technology portfolio relate to superior firm performance. However, the value of a firm’s technology portfolio should also be driven by the degree to which it is more unique and technologically... View Details
Keywords: Technology Portfolio; Differentiation; Competitiveness; Organizations; Technology; Performance; United States
Arts, Sam, Bruno Cassiman, and Jianan Hou. "Technology Differentiation and Firm Performance." Harvard Business School Working Paper, No. 22-040, December 2021.
- March 2020
- Article
Do Managers Matter? A Natural Experiment from 42 R&D Labs in India
By: Prithwiraj Choudhury, Tarun Khanna and Christos A. Makridis
We exploit plausibly exogenous variation in the staggered entry of new managers into India’s 42 public R&D labs between 1994 and 2006 to study how alignment between the CEO and middle-level managers affect research productivity. We show that the introduction of new lab... View Details
Keywords: Incentives; Innovation; Productivity; Management; Alignment; Research and Development; Innovation and Invention; Performance Productivity; India
Choudhury, Prithwiraj, Tarun Khanna, and Christos A. Makridis. "Do Managers Matter? A Natural Experiment from 42 R&D Labs in India." Journal of Law, Economics & Organization 36, no. 1 (March 2020): 47–83.
- 05 Sep 2006
- First Look
First Look: September 5, 2006
believing concentration is increasing even when it isn't, and to discuss possible reasons. What Is the Impact of Software Patent Shifts? Evidence from Lotus v. Borland Authors:Josh Lerner and Feng Zhu Periodical:International Journal of... View Details
Keywords: Sean Silverthorne
- 04 Dec 2018
- First Look
New Research and Ideas, December 4, 2018
public firms during this period were only 41% of net income. And, in fact, during this decade investment increased substantially while cash balances ballooned. In short, S&P 500 shareholder-payout figures cannot provide much basis for... View Details
Keywords: Dina Gerdeman
- January 2011
- Supplement
Matrix Capital Management (B)
By: Malcolm P. Baker and David Lane
Ben Balbale, a partner at hedge fund Matrix Capital, must decide whether to exit their investment in Rovi Corporation, a company with a diverse portfolio of patents used primarily for digital interactive guides. Rovi's shares are up over 50% from the time Balbale... View Details
Keywords: Public Ownership; Cash Flow; Management Analysis, Tools, and Techniques; Investment Funds; Financial Strategy; Valuation; Partners and Partnerships; Markets; Performance Efficiency; Patents; Stock Shares; Decisions; Financial Services Industry
Baker, Malcolm P., and David Lane. "Matrix Capital Management (B)." Harvard Business School Supplement 211-048, January 2011.